PTC Therapeutics (PTCT) Misses Q4 EPS by 63c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus
Go back to PTC Therapeutics (PTCT) Misses Q4 EPS by 63c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 71.39 -0.58 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.97 | 52 Week High | $35.40 | |||
| Open | $71.58 | 52 Week Low | $4.03 | |||
| Day High | $71.86 | P/E | 7.59 | |||
| Day Low | $70.85 | EPS | $9.40 | |||
| Volume | 46,819 | |||||
